Mapping the research addressing prescription drug monitoring programs: A scoping review

被引:10
作者
Hoppe, Dimi [1 ]
Karimi, Leila [1 ]
Khalil, Hanan [1 ]
机构
[1] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia
关键词
prescription drug monitoring programs; opioids; delivery of health care; PILL MILL LAWS; EMERGENCY-DEPARTMENT; UNITED-STATES; PRESCRIBING BEHAVIORS; NONMEDICAL USE; PRIMARY-CARE; MANDATED-USE; IMPACT; OVERDOSE; EDUCATION;
D O I
10.1111/dar.13431
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Issues Prescription drug monitoring programs are a harm minimisation intervention and clinical decision support tool that address the public health concern surrounding prescription drug misuse. Given the large number of studies published to date and the ongoing implementation of these programs, it is important to map the literature and identify areas for further research to improve practice. Approach A scoping review was undertaken to identify the research on prescription drug monitoring programs published between January 2015 and April 2021. Key Findings A total of 153 citations were included in this scoping review. The majority of the studies originated from the USA and were quantitative. Results on program effectiveness are mixed and mainly examine their association with opioid-related outcomes. Unintended consequences are revealed in the literature and this review also highlights barriers to program use. Implications Overall, findings are mixed despite the large number of studies published to date. Mapping the literature identifies priority areas for further research that can advise policymakers and clinicians on practice improvement. Conclusion Results on prescription drug monitoring program effectiveness are mixed and mainly examine their association with opioid-related outcomes. This review highlights barriers to prescription drug monitoring program effectiveness related to program use and system integration. Further research is needed in these areas to improve prescription drug monitoring program use and patient outcomes.
引用
收藏
页码:803 / 817
页数:15
相关论文
共 173 条
[11]   Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians [J].
Bao, Yuhua ;
Pan, Yijun ;
Taylor, Aryn ;
Radakrishnan, Sharmini ;
Luo, Feijun ;
Pincus, Harold Alan ;
Schackman, Bruce R. .
HEALTH AFFAIRS, 2016, 35 (06) :1045-1051
[12]   Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians [J].
Barth, Kelly S. ;
Ball, Sarah ;
Adams, Rachel S. ;
Nikitin, Ruslan ;
Wooten, Nikki R. ;
Qureshi, Zaina P. ;
Larson, Mary J. .
JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS, 2017, 37 (02) :98-105
[13]   A survey of Physicians' Perspectives on the New York State Mandatory Prescription Monitoring Program (ISTOP) [J].
Blum, Cary J. ;
Nelson, Lewis S. ;
Hoffman, Robert S. .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2016, 70 :35-43
[14]  
Bote Sunghee H, 2019, Online J Public Health Inform, V11, pe18, DOI 10.5210/ojphi.v11i2.10113
[15]   Time-Series Analysis of the Impact of Prescription Drug Monitoring Programs on Heroin Treatment Admissions [J].
Branham, Douglas Keith .
SUBSTANCE USE & MISUSE, 2018, 53 (04) :694-701
[16]   OB/GYN perceptions of prescription drug monitoring programs as a primary prevention tool for neonatal abstinence syndrome [J].
Brown, Joshua D. ;
Delcher, P. Chris ;
Bae, Jungjun ;
Roussos-Ross, Dikea ;
Goodin, Amie J. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (12) :1789-1791
[17]   Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity [J].
Brown, Richard ;
Riley, Moira R. ;
Ulrich, Lydia ;
Kraly, Ellen Percy ;
Jenkins, Paul ;
Krupa, Nicole L. ;
Gadomski, Anne .
DRUG AND ALCOHOL DEPENDENCE, 2017, 178 :348-354
[18]   Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study [J].
Brown, Whitnee C. ;
Whitted, Kelli .
JOURNAL OF DOCTORAL NURSING PRACTICE, 2020, 13 (02) :142-147
[19]   How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program [J].
Buchmueller, Thomas C. ;
Carey, Colleen M. ;
Meille, Giacomo .
HEALTH ECONOMICS, 2020, 29 (09) :957-974
[20]   Provider Compliance With Kentucky's Prescription Drug Monitoring Program's Mandate To Query Patient Opioid History [J].
Carey, Colleen M. ;
Meille, Giacomo ;
Buchmueller, Thomas C. .
HEALTH AFFAIRS, 2021, 40 (03) :461-468